Protego Biopharma

News

Our latest crop of biotech financings has nine-figure rounds for Protego and Triana, with Excelsior Sciences and SciNeuro also raising new funds.

News

Pharvaris has reported positive data from a phase 3 trial of its drug for preventing HAE attacks, setting up marketing applications next year.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.